Bank of Montreal
PRQR icon

Bank of Montreal’s ProQR Therapeutics PRQR Stock Holding History

Bank of Montreal’s Portfolio PRQR Stock Details PRQR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-30,000
Closed -$61.2K – 3757
2025
Q2 		$61.2K Hold
30,000
– – ﹤0.01% 3100
2025
Q1 		$39.9K Hold
30,000
– – ﹤0.01% 3110
2024
Q4 		$79.5K Hold
30,000
– – ﹤0.01% 3006
2024
Q3 		$54.9K Hold
30,000
– – ﹤0.01% 3394
2024
Q2 		$53.4K Hold
30,000
– – ﹤0.01% 3414
2024
Q1 		$73.2K Hold
30,000
– – ﹤0.01% 3366
2023
Q4 		$66.3K Buy
+30,000
New +$46.1K ﹤0.01% 3485
2023
Q1 		– Sell
-102,551
Closed -$381K – 4097
2022
Q4 		$381K Buy
+102,551
New +$134K ﹤0.01% 2769

Other funds holding PRQR

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PFM
Privium Fund Management Amsterdam, Netherlands $480M AUM 77.45% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Bank of Montreal's PRQR Position: Q3 2025 in Review

Bank of Montreal sold out of ProQR Therapeutics (PRQR) in Q3 2025, closing a stake of 30,000 shares — an estimated $61.2K sold.

Bank of Montreal first reported a position in PRQR in Q4 2022 and held it in 8 quarters. The position peaked at $381K in Q4 2022. 64 funds tracked by Wall St. Rank hold PRQR as of Q3 2025.

  • Bank of Montreal reported no remaining ProQR Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Bank of Montreal sold 30,000 ProQR Therapeutics shares in Q3 2025, an estimated $61.2K.
  • Bank of Montreal first reported a position in ProQR Therapeutics in Q4 2022 and held it in 8 quarters.
  • Bank of Montreal's ProQR Therapeutics position peaked at $381K in Q4 2022.
  • 64 funds tracked by Wall St. Rank held ProQR Therapeutics as of Q3 2025.

Based on Bank of Montreal's 13F filing for Q3 2025, filed 13 Nov 2025.